HIV Infection in Humanized Mice
$267,620ZIAFY2013AINIH
National Institute Of Allergy And Infectious Diseases
Investigators
Linked publications, trials & patents
Paper 30770827Paper 30085162Paper 29447279Paper 29112072Paper 27099312Paper 26670361Paper 26609939Paper 26529416Paper 24021673Patent 9771428Patent 11780931Patent 11230607Patent 10723803Patent 10184004
Abstract
This project has established an improved humanized mouse model for the study of immune responses to HIV infection and vaccination. The model utilizes severely immunocompromised mice reconstituted with human thymic and liver tissue, which establishes human lymphocytic and monocytic populations susceptible to HIV infection. The mice support both intravenous and mucosal HIV infection and develop HIV-specific B and T cell immunity. We have been studying vaccine responses in the animals and are working on methods to improve vaccine efficacy and strengthen immune responses in humanized mice.
View original record on NIH RePORTER →